Recent transactions
| Filed | Insider | Role | Type | Shares | Price | Value | |
|---|---|---|---|---|---|---|---|
| Jun 24, 2026 | Saccomano Nicholas A | Pres, CEO | S Sale | — | $4.40 | $378 | filing |
| Jun 24, 2026 | Leverone Jason A. | CFO | S Sale | — | $4.40 | $1K | filing |
ONKURE THERAPEUTICS A (OKUR) insider trading activity (SEC Form 4). Over the trailing 90 days, OKUR insiders filed 0 purchases totalling $0 and 2 sales totalling $2K — net SELLING of $2K. Most recent filing: Jun 24, 2026. Insider transactions are a Pro-tier alertable signal in the live Top Tier Newswire terminal — Form 4 filings reach the wire within minutes of acceptance by the SEC. Data shown publicly here is delayed 4 hours.